Records 1 - 11
| Communication processes about predictive genetic testing within high-risk breast cancer families: a two-phase study design.
Scientific reports 2021 Oct 11 (1): 20178.
Blomen Chiara L, Pott Aliaksandra, Volk Alexander E, Budäus Lars, Witzel Isabe
| Combined breast conservation therapy versus mastectomy for BRCA mutation carriers - A systematic review and meta-analysis.
Breast (Edinburgh, Scotland) 2021 Feb 56 26-34.
Davey M G, Davey C M, Ryan É J, Lowery A J, Kerin M
| Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: Overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy.
Cancer 2016 Apr .
Matulonis Ursula A, Harter Philipp, Gourley Charlie, Friedlander Michael, Vergote Ignace, Rustin Gordon, Scott Clare, Meier Werner, Shapira-Frommer Ronnie, Safra Tamar, Matei Daniela, Fielding Anitra, Spencer Stuart, Parry David, Grinsted Lynda, Ledermann Jonathan
| Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility.
BMC medical genomics 2015 8 (1): 72.
Piccolo Stephen R, Andrulis Irene L, Cohen Adam L, Conner Thomas, Moos Philip J, Spira Avrum E, Buys Saundra S, Johnson W Evan, Bild Andrea
| Prevalence of BRCA1 and BRCA2 mutations in women with breast carcinoma In Situ and referred for genetic testing.
Cancer prevention research (Philadelphia, Pa.) 2010 Dec 3 (12): 1579-85.
Hall Michael J, Reid Julia E, Wenstrup Richard
| BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.
Cancer 2009 May 115 (10): 2222-33.
Hall Michael J, Reid Julia E, Burbidge Lynn A, Pruss Dmitry, Deffenbaugh Amie M, Frye Cynthia, Wenstrup Richard J, Ward Brian E, Scholl Thomas A, Noll Walter
| Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Feb 15 (3): 1112-20.
Agalliu Ilir, Gern Robert, Leanza Suzanne, Burk Robert
| Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
American journal of medical genetics. Part A 2004 Feb 124A (4): 346-55.
van Roosmalen Mariëlle S, Stalmeier P F M, Verhoef L C G, Hoekstra-Weebers J E H M, Oosterwijk J C, Hoogerbrugge N, Moog U, van Daal W A
| A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Breast cancer research : BCR 2004 6 (1): R8-R17.
Robson Mark E, Chappuis Pierre O, Satagopan Jaya, Wong Nora, Boyd Jeff, Goffin John R, Hudis Clifford, Roberge David, Norton Larry, Bégin Louis R, Offit Kenneth, Foulkes William
| Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.
Genetic testing 2004 8 (1): 13-21.
Claes Erna, Evers-Kiebooms Gerry, Boogaerts Andrea, Decruyenaere Marleen, Denayer Lieve, Legius Er
| A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2002 Nov 21 (6): 564-72.
Cella David, Hughes Chanita, Peterman Amy, Chang Chih-Hung, Peshkin Beth N, Schwartz Marc D, Wenzel Lari, Lemke Amy, Marcus Alfred C, Lerman Car